Nuvation Bio (NUVB) Q4 2024 Annual Earnings
NUVB·Reported March 6, 2025·Before market open
Nuvation Bio reported Q4 2024 revenue of $5.7M, beat analyst consensus of $833.3K by $4.9M. Diluted EPS came in at $-0.15, missed the $-0.14 consensus by $0.01.
Revenue
$5.7Mbeat by $4.9M
Consensus: $833.3KDiluted EPS
$-0.15missed by $0.01
Consensus: $-0.14
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Nuvation Bio's Q4 2024 earnings report.
Nuvation Bio (NUVB) reported Q4 2024 earnings on March 6, 2025 before market open.
Nuvation Bio reported revenue of $5.7M and diluted EPS of $-0.15 for Q4 2024.
Revenue beat the consensus estimate of $833.3K by $4.9M. EPS missed the consensus estimate of $-0.14 by $0.01.
You can read the 10-K periodic report (0000950170-25-034903) directly on SEC EDGAR. The filing index links above go to sec.gov.